JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 30 No. 4 538-541
© 1989 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Issachar, D.
Right arrow Articles by Trumper, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Issachar, D.
Right arrow Articles by Trumper, J.

Osmium-191/Iridium-191m Generator Based on Silica Gel Impregnated with Tridodecylmethylammonium Chloride

David Issachar, Shmuel Abrashkin, Jolie Weininger, Dvora Zemach, Ernesto Lubin, Chaim Hellman and Jacob Trumper

Radiopharmaceuticals Department, Soreq Nuclear Research Center, Yavne 70600
Division of Nuclear Medicine, Beilinson Hospital, Sackler School of Medicine, Tel-Aviv University, Petah Tiqwe, Israel

Correspondence: For reprints contact: David Issachar, PhD, Radiopharmaceuticals Dept., Soreq Nuclear Research Center, Yavne 70600, Israel.

ABSTRACT

A new separation system for an 191Os/191mIr generator is described. The system is composed of two columns in a series: a main column, packed with silica gel impregnated with tridodecylmethylammonium chloride (loaded with high activity 191Os as an osmyl chloride); and a scavenger column, packed with activated charcoal. Iridium-191m is eluted from the generator by pH 1 saline. For clinical use the eluate is buffered by succinate solution before injection. This new system is characterized by high performance (~ 25% 191mIr recovery with 5 x 10–4% 191Os breakthrough) and long shelf-life (3 wk). The buffered eluate is sterile, pyrogen-free, and nontoxic, and contains no 192Ir. It is suitable for first-pass radionuclide angiocardiography with a very low radiation dose to the patient.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1989 by the Society of Nuclear Medicine.